265 related articles for article (PubMed ID: 18298297)
1. Invariant natural killer T cells in immune surveillance and tumor immunotherapy: perspectives and potentials.
Haeryfar SM
Arch Iran Med; 2008 Mar; 11(2):186-95. PubMed ID: 18298297
[TBL] [Abstract][Full Text] [Related]
2. Invariant natural killer T cells and immunotherapy of cancer.
Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of natural killer T cell-based immunotherapy for cancer.
Motohashi S; Nakayama T
Cancer Sci; 2008 Apr; 99(4):638-45. PubMed ID: 18294290
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
Guo H; Qian X
Onkologie; 2010; 33(7):389-95. PubMed ID: 20631487
[TBL] [Abstract][Full Text] [Related]
5. Cellular therapy of cancer with natural killer cells-where do we stand?
Klingemann HG
Cytotherapy; 2013 Oct; 15(10):1185-94. PubMed ID: 23768925
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified immune cells for cancer immunotherapy.
Jiang L; Wang W
Sci China Life Sci; 2018 Oct; 61(10):1277-1279. PubMed ID: 30276708
[No Abstract] [Full Text] [Related]
7. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
8. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
van der Vliet HJ; Molling JW; Nishi N; Masterson AJ; Kölgen W; Porcelli SA; van den Eertwegh AJ; von Blomberg BM; Pinedo HM; Giaccone G; Scheper RJ
Cancer Res; 2003 Jul; 63(14):4101-6. PubMed ID: 12874013
[TBL] [Abstract][Full Text] [Related]
9. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
11. Identification and activation of tumor-reactive cells for adoptive immunotherapy.
Triozzi PL
Stem Cells; 1993 May; 11(3):204-11. PubMed ID: 8318907
[TBL] [Abstract][Full Text] [Related]
12. T-cell-associated cellular immunotherapy for lung cancer.
Li K; Zhang Q; Zhang Y; Yang J; Zheng J
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1249-58. PubMed ID: 25381064
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells and tumor immunity: 1987.
Hiserodt JC; Herberman RB
Year Immunol; 1989; 4():201-7. PubMed ID: 2648702
[No Abstract] [Full Text] [Related]
14. Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.
Tonn T; Becker S; Esser R; Schwabe D; Seifried E
J Hematother Stem Cell Res; 2001 Aug; 10(4):535-44. PubMed ID: 11522236
[TBL] [Abstract][Full Text] [Related]
15. NK cell-based cancer immunotherapy: from basic biology to clinical application.
Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X
Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912
[TBL] [Abstract][Full Text] [Related]
16. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
17. Natural killer T cell anergy, co-stimulatory molecules and immunotherapeutic interventions.
Singh AK; Gaur P; Das SN
Hum Immunol; 2014 Mar; 75(3):250-60. PubMed ID: 24373798
[TBL] [Abstract][Full Text] [Related]
18. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.
Cohen PA; Peng L; Kjaergaard J; Plautz GE; Finke JH; Koski GK; Czerniecki BJ; Shu S
Crit Rev Immunol; 2001; 21(1-3):215-48. PubMed ID: 11642606
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection.
Miller G; Lahrs S; Pillarisetty VG; Shah AB; DeMatteo RP
Cancer Res; 2002 Sep; 62(18):5260-6. PubMed ID: 12234994
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulation of autoimmunity by natural killer T cells.
Linsen L; Somers V; Stinissen P
Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
